Discovery and characterization of a new platform of drugs to address multi-drug resistance in pathogenic bacteria

The evolving resistance of pathogenic (bad) bacteria to antibiotics is already causing a large number of illnesses and deaths not only in Canada but throughout the world. Countries are calling desperately for new drugs to address these bacteria that are becoming untreatable by current drugs. Viotika Life Sciences has identified a new platform of drugs that may circumvent this resistance and save lives in the process.